Human NK Cell Education by Inhibitory Receptors for MHC Class I
2006 · Immunity · 1,141 citations
https://doi.org/10.1016/j.immuni.2006.06.013
S
Sophie Guia
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
4.0K
Citations
23
h-index
28
i10-index
Sophie Guia is an academic researcher from Inserm. The author has contributed to research in topics: Immune Cell Function and Interaction & T-cell and B-cell Immunology & CAR-T cell therapy research. The author has an h-index of 23, co-authored 30 publications.
ORCID: 0000-0001-8405-4687Papers by this author
worksAnti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
2018 · Cell · 1,136 citations
https://doi.org/10.1016/j.cell.2018.10.014
Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance
2011 · Science Signaling · 135 citations
https://doi.org/10.1126/scisignal.2001608
Manufacturing Natural Killer Cells as Medicinal Products
2016 · Frontiers in Immunology · 41 citations
https://doi.org/10.3389/fimmu.2016.00504
Engagement of Natural Cytotoxicity Programs Regulates AP-1 Expression in the NKL Human NK Cell Line
1999 · The Journal of Immunology · 26 citations
https://doi.org/10.4049/jimmunol.162.7.4062
Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing
2025 · Journal for ImmunoTherapy of Cancer · 4 citations
https://doi.org/10.1136/jitc-2024-010699
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat